Skip to content

Effect of lactose restricted diet in the treatment of pediatric acute diarrhea

Effect of lactose restricted diet in the treatment of pediatric acute diarrhea treated with zinc

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016031326973N1
Enrollment
90
Registered
2016-03-13
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute diarrhea. Intestinal infectious diseases

Interventions

Intervention Group: zinc sulfat syrup(daily 20mg) and lactose restricted diet (continued breastfeeding along with the elimination of lactose from the diet, especially the elimination of milk and the
Treatment - Drugs

Sponsors

Vice Chancellor for research- Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 2 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:children 6 months to 2 years with acute watery diarrhea(i.e.3 or more stools per day for less than 72 h) Exclusion criteria:children under 6 months and more than two years, blood in the stool (dysentery infectious and non-infectious), more than 3 days have passed since the onset of diarrhea, recent use of antibiotics, organic diseases (heart, kidney, etc. .) is known, severe malnutrition (weight for age <60% and/or weight for height <70%), Where diarrhea is causing complications such as seizures and ileus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The number of defication per day. Timepoint: Before the intervention, the duration of intervention for 14 days, at the end of intervention. Method of measurement: Improve the diarrhea is defined as the number of bowel movements fewer than three times in 24 hours.

Secondary

MeasureTime frame
There are possible side effects of the drug and lactose-free supplement. Timepoint: During the study period and at the end of the study. Method of measurement: according to patiants.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSanaz Mehrabani

Babol University of Medical Sciences

s.mehrabani@mubabol.ac.ir , mehrabanisanaz@yahoo.com , tarahomir@gmail.com+98 11 3219 7667

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026